Oshrat Hershkovitz-Rokah

12PUBLICATIONS

64CO-AUTHORS

Tumour immunologyBehavioural epidemiologyAutoimmunityGene and molecular therapyHaematological tumours

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Jun 23, 2026

Loss of miR-146a-5p contributes to ibrutinib resistance in mantle cell lymphoma.

|Oct 09, 2025

Epigenetic dysregulation in Erdheim-Chester disease: perspectives from tissue and blood.

Refael Meyuchas, Ofer Shpilberg, Oshrat Hershkovitz-Rokah

|Apr 11, 2025

The molecular landscape of AL amyloidosis.

Tal Zvida-Bloch, Eli Muchtar, Angela Dispenzieri

|Nov 08, 2024

The effect of methylation on the let-7-BCL2L1-BCL2 axis and the potential use of hypomethylating and BH3 mimetic drugs in histiocytic neoplasms.

Mali Salmon-Divon, Refael Meyuchas, Ofer Shpilberg

|Apr 13, 2024

Mixed histiocytic neoplasms: A multicentre series revealing diverse somatic mutations and responses to targeted therapy.

Joshua S Friedman, Benjamin H Durham, Anne S Reiner

|Oct 24, 2023

Mutant PIK3CA is a targetable driver alteration in histiocytic neoplasms.

Benjamin H Durham, Oshrat Hershkovitz-Rokah, Omar Abdel-Wahab

Pageof 2

Frequent Collaborators

Eli L Diamond

Ofer Shpilberg

Mali Salmon-Divon

Benjamin H Durham

Roei David Mazor

Refael Meyuchas

Eli Muchtar

Seyram A Doe-Tetteh

Martin Dreyling

Guy Shapira

Frequent Collaborators

Eli L Diamond

Ofer Shpilberg

Mali Salmon-Divon

Benjamin H Durham